| 标题 |
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY ASSESSING THE SAFETY AND EFFICACY OF TOFACITINIB IN HOSPITALIZED PARTICIPANTS WITH COVID-19 PNEUMONIA WHO ARE RECEIVING STANDARD OF CARE THERAPY
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供，该求助的时间将会延长，查看原因？
|
| 其它 | Brief Summary The study is designed as a multicenter, randomized, double-blind, placebo-controlled, parallel group study of the safety and efficacy of tofacitinib in hospitalized adult participants with COVID-19 pneumonia who are receiving SoC therapy and who are not on HFNC, noninvasive ventilation, invasive mechanical ventilation, or ECMO on Day 1 at the time of randomization. Participants with laboratory confirmed SARS-CoV-2 infection as determined by a positive PCR or other |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
牧青
v0id
璐璐
林狗
愉快的真
lalala
学霸业
OK
嘻嘻哈哈
GingerF
刻苦若之
学术文献互助
aajhajkahna
DW
谢雷XIELei
极限001
lili
changping
SIyuan
我爱小高
皖公网安备34019202002308
